Who owns Xbiotech?
- Ticker: XBIT
- CUSIP Number: 98400h102
Tip: Access positions for across all investors
Analyze quarterly positions in Xbiotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xbiotech stock
Who bought or sold Xbiotech this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 1.3M | $9.7M | 100% | Sep 2024 |
|
| BlackRock | 1.1M | $5.8M | 270% | Jun 2024 |
|
| Vanguard Group | 1.0M | $5.3M | 16% | Jun 2024 |
|
| Geode Capital Management | 452k | $3.5M | 5% | Sep 2024 |
|
| State Street Corporation | 203k | $1.0M | 259% | Jun 2024 |
|
| Northern Trust | 184k | $1.4M | 143% | Sep 2024 |
|
| Bridgeway Capital Management | 154k | $793k | 3% | Jun 2024 |
|
| American Century Companies | 130k | $1.0M | 70% | Sep 2024 |
|
| Morgan Stanley | 101k | $517k | -14% | Jun 2024 |
|
| Bank of New York Mellon | 85k | $655k | -14% | Sep 2024 |
|
| Connor, Clark & Lunn Investment Management | 76k | $585k | -3% | Sep 2024 |
|
| Dimensional Fund Advisors | 73k | $560k | 0% | Sep 2024 |
|
| Empowered Funds | 63k | $484k | -10% | Sep 2024 |
|
| Charles Schwab Investment Management | 58k | $452k | 8% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 40k | $310k | 185% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 33k | $255k | 0% | Sep 2024 |
|
| Barclays | 26k | $204k | 247% | Sep 2024 |
|
| Nuveen Asset Management | 25k | $128k | 100% | Jun 2024 |
|
| T. Rowe Price Associates | 24k | $183k | 0% | Sep 2024 |
|
| Rhumbline Advisers | 21k | $164k | 6% | Sep 2024 |
|
| Alpine Partners VI | 18k | $92k | 100% | Jun 2024 |
|
| Citigroup | 15k | $112k | 249% | Sep 2024 |
|
| Bank of America Corporation | 14k | $108k | 35% | Sep 2024 |
|
| TNB Financial | 13k | $103k | 0% | Sep 2024 |
|
| Goldman Sachs Group | 13k | $68k | -79% | Jun 2024 |
|
| Qube Research & Technologies | 13k | $66k | -81% | Jun 2024 |
|
| MetLife Investment Advisors | 12k | $94k | 100% | Sep 2024 |
|
| Synovus Financial Corp. | 12k | $91k | 0% | Sep 2024 |
|
| Jane Street | 11k | $86k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 10k | $79k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 9.2k | $71k | 13% | Sep 2024 |
|
| Jpmorgan Chase & Co | 8.7k | $67k | 10% | Sep 2024 |
|
| Royal Bank of Canada | 2.4k | $21k | 25% | Sep 2024 |
|
| Summit Investment Advisors | 1.8k | $14k | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 1.6k | $12k | -93% | Sep 2024 |
|
| California State Teachers Retirement System | 1.5k | $12k | 11% | Sep 2024 |
|
| Amalgamated Bank | 640.00 | $5.0k | 0% | Sep 2024 |
|
| Simplex Trading | 159.00 | $999.998700 | 28% | Sep 2024 |
|
| Us Bancorp | 100.00 | $773.000000 | 0% | Sep 2024 |
|
| Sachetta | 100.00 | $773.000000 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 88.00 | $680.002400 | 100% | Sep 2024 |
|
| Smartleaf Asset Management | 84.00 | $605.001600 | 100% | Sep 2024 |
|
| Sterling Capital Management | 59.00 | $455.999200 | 100% | Sep 2024 |
|
| CWM | 34.00 | $0 | 100% | Sep 2024 |
|
| Tower Research Capital | 33.00 | $169.999500 | -97% | Jun 2024 |
|
| Capital Performance Advisors | 1.00 | $8.000000 | 100% | Sep 2024 |
|
Who sold out of Xbiotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 362k | $1.9M |
| Balyasny Asset Management | Mar 2024 | 22k | $178k |
| Two Sigma Advisers | Mar 2024 | 18k | $150k |
| ExodusPoint Capital Management | Mar 2024 | 16k | $132k |
| Citadel Advisors | Jun 2024 | 15k | $79k |
| Two Sigma Investments | Mar 2024 | 11k | $87k |
| Man Group | Jun 2024 | 11k | $55k |
| Marshall Wace | Jun 2024 | 11k | $54k |
| Macquarie Group | Mar 2024 | 576.00 | $5.011200 |